LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Clinical trials for LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on advanced throat cancer begins testing
Disease control Not yet recruitingThis study is testing whether adding two immunotherapy drugs (pembrolizumab and MRG-003) before and after standard chemoradiation can better control advanced nasopharyngeal cancer. It will involve about 35 adults with a specific type of this cancer linked to the Epstein-Barr viru…
Matched conditions: LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New drug showdown: can it outperform standard pills to keep advanced throat cancer at bay?
Disease control Not yet recruitingThis study aims to see if a new intravenous drug, Becotatug Vedotin, works better than the standard oral chemotherapy (capecitabine) at preventing cancer from coming back in people with high-risk, advanced nasopharyngeal carcinoma (a type of throat cancer). It will involve about …
Matched conditions: LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC